Wednesday, October 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home European Markets

Nel ASA Shifts the Narrative from Climate to Security as a Cost Breakthrough Fails to Move the Needle

Rodolfo Hanigan by Rodolfo Hanigan
July 7, 2026
in European Markets, Hydrogen, Renewable Energy
0
Nel ASA Stock
0
SHARES
64
VIEWS
Share on FacebookShare on Twitter

The clean hydrogen industry has long sold itself on environmental salvation, but Nel ASA’s chief executive is now reaching for a different script. Instead of carbon targets, Håkon Volldal is talking about energy independence, resilience, and even defence applications — a strategic pivot that comes at a time when the company’s order book is bleeding and its stock is trading near multi-month lows.

Volldal has been upfront about the recalibration. “I don’t think it’s particularly controversial to say that we need to rethink our energy system,” he said recently, arguing that locally produced renewable hydrogen reduces dependence on centralised, volatile energy sources. The message leans less on climate ambition and more on strategic autonomy — a selling point that could open up a second demand channel beyond pure decarbonisation subsidies. Yet the market has so far greeted the shift with a shrug. The shares closed at €0.21 on Monday, down 0.94% on the day and nearly a quarter lower over the past month.

The technology story, meanwhile, has genuinely improved. In May 2026, Nel commercially launched its new pressurised alkaline electrolyser system, targeting full costs below $1,450 per kilowatt for a 25-megawatt installation — roughly half the typical industry benchmark of $3,000/kW. The EU Innovation Fund is backing the industrialisation at Herøya in Norway with up to €135 million, covering as much as 60% of eligible costs. The site is designed for an initial annual capacity of one gigawatt, with expansion potential to four gigawatts.

But a leap in product efficiency does not automatically translate into revenue. Nel’s first-quarter 2026 numbers laid bare the gap. Order intake collapsed 73% year-on-year to 85 million Norwegian kroner, while the order backlog shrank 24% to 1.113 billion kroner. EBITDA came in at negative 100 million kroner. To make matters worse, the company recently stopped publishing formal analyst consensus estimates because too few analysts were covering the stock — a sign that institutional visibility is fading just when it is needed most.

Should investors sell immediately? Or is it worth buying Nel ASA?

Adding to the uncertainty, Volldal announced his departure in June 2026. He will stay on for another six months while the board searches for a successor, meaning the company enters a critical scaling phase with a lame-duck CEO at the helm. Leadership vacuums rarely help when the sales pipeline needs urgent conversion.

The share price tells a story of trapped momentum. At €0.21, the stock sits 42.54% below its 52-week high of €0.37 set on 25 May, though it remains 21.32% above the year’s low of €0.17 from February. The 50-day moving average of €0.27 represents a 20.95% gap to the upside, while the 200-day average of €0.22 is only 2.37% above the current level — suggesting that the spring rally has been completely unwound and the equity now rests near its longer-term equilibrium. The 14-day relative strength index of 37.2 is flirting with oversold territory, and the annualised 30-day volatility of 66.38% underlines how violently sentiment can swing. Since the start of the year, performance has been mixed: one measure shows a gain of 9.55%, while another calculation puts the advance at 10.59%.

The security argument Volldal is making does not emerge from a vacuum. Several regions are now issuing large-scale hydrogen tenders, and Nel’s competitors in the electrolyser space have posted wildly different results — from margin-positive fuel-cell earnings to subsidy-driven share rallies for players with deep industrial partnerships. A supportive macro theme does not automatically mean orders for any single company.

What the resilience narrative does offer is a second source of demand that could diversify Nel’s revenue base beyond classic climate subsidies. But for now, the immediate catalyst remains the second-quarter earnings report, due between 15 and 20 July. The market will be watching for evidence that the cost breakthrough has started to translate into signed contracts — and whether the order intake has bottomed out. Until that happens, Nel’s stock is likely to remain pinned between its technological promise and its operational reality, with the security message as an intriguing but unproven wild card.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from October 6 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 6.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
TKMS Stock
Defense & Aerospace

TKMS Closes the Dolphin Chapter and Courts Fincantieri — But Shareholders Are Still Waiting for the Tide to Turn

September 7, 2026
Hensoldt Stock
Defense & Aerospace

Hensoldt’s €10 Billion Backlog Meets a 32% Drawdown: The Bull-Bear Fault Line Widening in Taufkirchen

September 7, 2026
Next Post
Commerzbank Stock

Commerzbank’s 1% Acceptance: How UniCredit Built a 40% Stake Without Most Shareholders’ Backing

FALLBACK Stock

From World Records to Spinal Implants: The New Arsenal Against Back Pain

BMW Stock

BMW's Preference Share Conversion and Index Expulsion Create Crosswinds for Beaten-Down Stock

Recommended

Amicus Therapeutics Stock

Amicus Therapeutics: A Biotech Stock Facing Divergent Views

1 year ago
MicroStrategy Stock

Insider Selling Sparks Concern at Strategy Holdings

12 months ago
ReconAfrica Stock

ReconAfrica Advances with Crucial Field Testing in Namibia

6 months ago
Shutterstock Stock

Shutterstock Stock Presents a Compelling Value Proposition

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

From GPUs to Guardrails: Q4’s Security Rotation Begins

The Rate Plateau’s Real Winners Aren’t Chipmakers

The K-Shaped Economy Meets a 19-Year High in Yields

Consumer Strength Meets Bond Market Stress Ahead of Q4

Borrowed Bull: Record Margin Debt Meets a Record Foreign Inflow

Trending

PepsiCo Stock
Newsletter

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

by Stephanie Dugan
October 6, 2026
0

Dear readers, Wall Street is at record levels, and the stocks that depend on household spending are...

Oracle Stock

Cash Flow Beats Backlog as Banks Brace for Earnings

October 5, 2026
AMD Stock

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

October 3, 2026
Nike Stock

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

October 2, 2026
Alphabet Stock

From GPUs to Guardrails: Q4’s Security Rotation Begins

October 1, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records
  • Cash Flow Beats Backlog as Banks Brace for Earnings
  • Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com